Verizon Communications Inc. (LON:0Q1S)

Market Cap	134.93B
Revenue (ttm)	100.00B
Net Income (ttm)	13.28B
Shares Out	n/a
EPS (ttm)	3.14
PE Ratio	10.16
Forward PE	9.10
Dividend	2.10 (4.87%)
Ex-Dividend Date	Jul 10, 2025

Volume	7,757
Average Volume	21,996
Open	43.17
Previous Close	43.06
Day's Range	43.17 - 43.63
52-Week Range	36.70 - 47.34
Beta	0.36
RSI	59.86
Earnings Date	Jul 21, 2025

About Revance Therapeutics

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadba...

• Industry: Radiotelephone Communications
• Founded: 1983
• Employees: 99,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1S

Financial Performance

In 2024, Verizon Communications's revenue was $134.79 billion, an increase of 0.61% compared to the previous year's $133.97 billion. Earnings were $17.51 billion, an increase of 50.73%.